WS02.3 Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD)
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Journal of cystic fibrosis - 14(2015), Seite S3 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Olivier, K.N [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1016/S1569-1993(15)30009-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1961264951 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1961264951 | ||
| 003 | DE-627 | ||
| 005 | 20230513190410.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1569-1993(15)30009-6 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1961264951 | ||
| 035 | |a (DE-599)GBVOLC1961264951 | ||
| 035 | |a (PRQ)crossref_primary_10_1016_S1569_1993_15_30009_60 | ||
| 035 | |a (KEY)0488987820150000014000000003ws023randomizeddoubleblinddbplacebocontrolledstudy | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Olivier, K.N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a WS02.3 Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD) |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Eagle, G |4 oth | |
| 700 | 1 | |a McGinnis, J.P |4 oth | |
| 700 | 1 | |a Micioni, L |4 oth | |
| 700 | 1 | |a Daley, C.L |4 oth | |
| 700 | 1 | |a Winthrop, K.L |4 oth | |
| 700 | 1 | |a Ruoss, S |4 oth | |
| 700 | 1 | |a Addrizzo-Harris, D.J |4 oth | |
| 700 | 1 | |a Flume, P |4 oth | |
| 700 | 1 | |a Dorgan, D |4 oth | |
| 700 | 1 | |a Salathe, M |4 oth | |
| 700 | 1 | |a Brown-Elliott, B.A |4 oth | |
| 700 | 1 | |a Wallace, R |4 oth | |
| 700 | 1 | |a Griffith, D.E |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cystic fibrosis |d Amsterdam [u.a.] : Elsevier, 2002 |g 14(2015), Seite S3 |w (DE-627)352108304 |w (DE-600)2084724-5 |x 1569-1993 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2015 |g pages:S3 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/S1569-1993(15)30009-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2015 |h S3 | ||